Modulation of endothelial cell function by antiphospholipid antibodies

Lupus

Volumn 5, Issue 5, 1996, Pages 448-450

  Meroni, P L ^a   Del Papa, N ^a   Beltrami, B ^a   Tincani, A ^b   Balestrieri, G ^b   Krilis, S A ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adhesion molecules; Antiphospholipid antibodies; Cytokines; Endothelial cells; Prostacyclin; Thrombosis

Indexed keywords

ARACHIDONIC ACID; BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; ENDOTHELIUM CELL; PRIORITY JOURNAL;

EID: 0029807892     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500523     Document Type: Conference Paper

References (27)

1. Carreras LO et al. Arterial thrombosis, intrauterine death and 'lupus' anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246.
2. Carreras LO, Vermylen J. Lupus anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48: 38-40.
3. Vermylen J, Arnout J. Is the anti-phospholipid syndrome caused by antibodies against physiologically relevant phospholipid-protein complex?. J Lab Clin Med 1992; 120: 10-12.
4. Vismara A et al. Relationship between anticardiolipin and anti-endothelial cell antibodies in SLE. Clin Exp Immunol 1988; 74: 247-253.
5. Hasselaar P, Derksen RHW, Blokzijl L, de Groot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990; 63: 169-173.
6. Cervera R et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991; 11: 1-6.
7. McCrae KR et al. Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 1991; 79: 595-605.
8. Del Papa N et al. Relationship between anticardiolipin and antiendothelial cell antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1992; 10: 37-42.
9. Del Papa N et al. Characterization of anti-endothehal cell antibodies in antiphospholipid syndrome. In: Polli EE (ed) Molecular Bases of Human Diseases. Excerpta Medica: Amsterdam 1993, 67-74.
10. Del Papa N et al. Relationship between antiphospholipid and antiendothelial cell antibodies III: β2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-186.
11. Le Tonquze M et al. Is there a role for β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells?. Lupus 1995; 4: 179-186.
12. Del Papa N et al. Beta 2 glycoprotein I binds to endothelial cell membranes independently from the cofactor phospholipid binding site and offers suitable epitopes for circulating anti-beta 2 glycoprotein I antibodies. Abstract submitted to the 7th International Symposium on Antiphospholipid Antibodies, New Orleans, October 9-13 1996.
13. Del Papa N et al. Human monoclonal anti-cardiolipin antibodies react in vitro with endothelial cells through the adhered beta 2 glycoprotein 1 and induce endothelial activation. Arthr Rheum 1995; 38 (suppl): S390.
14. Del Papa N et al. Endothelial cells as target for anti-phospholipid antibodies: human polyclonal and monoclonal anti-beta 2 glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2 glycoprotein I and induce endothelial activation. Submitted.
15. Roubey RAS. Autoantibodies to phosphohpid-binding plasma proteins: a new view of lupus anticoagulant and other 'antiphospholipid' autoantibodies. Blood 1994; 9: 2854-2867.
16. Arvieaux J, Roussel B, Jacob MC, Columb MG. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Methods 1991; 143: 223.
17. Viard JP, Amoura Z, Bach JF Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181.
18. Cabral AR, Rodrigeuz M, Cabiedes J, Alarcon Segovia D. Antibodies to β2-glycoprotein I associate with antiphospholipid syndrome whether primary (PAPS) or secondary to systemic lupus erythematosus. Arthritis Rheum 1993; 6 (suppl): S242.
19. Balestrieri G et al. Anti-β2 glycoprotein I antibodies: a marker of antiphospholipid syndrome. Lupus 1995; 4: 122.
20. Martinuzzo ME, Forastiero RR, Carerras LO. Anti-2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397.
21. Simantov R et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
22. Carreras LA, Maclouf J. Antiphospholipid antibodies and eisosanoids. Lupus 1994; 3: 271-273.
23. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukocyte Biol 1993; 54: 363-378.
24. Lellouche F et al. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 1991; 78: 2894-2898.
25. Vazquez-Mellado J, Llorente P, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of β2 glycoprotein I and through it IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmunity 1994; 12: 122-126.
26. McIntre JA. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992; 28: 127-131.
27. La Rosa L et al. β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with anti-phosphohpid syndrome. J Rheumatol 1994; 21: 1684-1698.